SOTERA HEALTH COMPANY Other Comprehensive Income (Loss), before Reclassifications, Net of Tax
SOTERA HEALTH COMPANY (SHC) reported Other Comprehensive Income (Loss), before Reclassifications, Net of Tax of $19.07 million for the 3-month period ending 2025-03-31, per its 10-Q filed 2025-05-01.
Financial Statements › Income Statement › Unrealized Gains
us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax · last filed 2025-05-01
- SOTERA HEALTH COMPANY other comprehensive income (loss), before reclassifications, net of tax for the quarter ending 2025-03-31 was $19.07M.
- SOTERA HEALTH COMPANY other comprehensive income (loss), before reclassifications, net of tax for the quarter ending 2024-06-30 was -$21.87M, a 167.53% decline year-over-year.
- SOTERA HEALTH COMPANY other comprehensive income (loss), before reclassifications, net of tax for the quarter ending 2024-03-31 was -$23.51M, a 368.46% decline year-over-year.
- SOTERA HEALTH COMPANY other comprehensive income (loss), before reclassifications, net of tax for the quarter ending 2023-06-30 was $32.39M.
- SOTERA HEALTH COMPANY other comprehensive income (loss), before reclassifications, net of tax for fiscal 2024 was -$105.55M, a 390.73% decline from fiscal 2023.
- SOTERA HEALTH COMPANY other comprehensive income (loss), before reclassifications, net of tax for fiscal 2023 was $36.31M.
- SOTERA HEALTH COMPANY other comprehensive income (loss), before reclassifications, net of tax for fiscal 2022 was -$23.07M, a 349.96% decline from fiscal 2021.
- SOTERA HEALTH COMPANY other comprehensive income (loss), before reclassifications, net of tax for fiscal 2021 was $9.23M.
| Period end | Other Comprehensive Income (Loss), before Reclassifications, Net of Tax 3 month | Other Comprehensive Income (Loss), before Reclassifications, Net of Tax 6 month | Other Comprehensive Income (Loss), before Reclassifications, Net of Tax 12 month |
|---|---|---|---|
| 2025-03-31 | $19.07M 10-Q · filed 2025-05-01 | ||
| 2024-12-31 | -$105.55M 10-K · filed 2025-02-27 | ||
| 2024-06-30 | -$21.87M 10-Q · filed 2024-08-05 | -$45.38M 10-Q · filed 2024-08-05 | |
| 2024-03-31 | -$23.51M 10-Q · filed 2025-05-01 | ||
| 2023-12-31 | $36.31M 10-K · filed 2025-02-27 | ||
| 2023-06-30 | $32.39M 10-Q · filed 2024-08-05 | $41.24M 10-Q · filed 2024-08-05 | |
| 2023-03-31 | $8.76M 10-Q · filed 2024-05-02 | ||
| 2022-12-31 | -$23.07M 10-K · filed 2025-02-27 | ||
| 2022-06-30 | -$42.33M 10-Q · filed 2023-08-03 | -$21.44M 10-Q · filed 2023-08-03 | |
| 2021-12-31 | $9.23M 10-K · filed 2024-02-27 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Progyny, Inc. (PGNY) | United States | $1.994B | 28.37 |
| agilon health, inc. (AGL) | United States | $1.272B | -7.76 |
| VIEMED HEALTHCARE, INC. (VMD) | United States | $0.336B | 29.92 |
| Park Dental Partners, Inc. (PARK) | United States | $0.094B | |
| BioRestorative Therapies, Inc. (BRTX) | United States | $0.064B | |
| CRYO CELL INTERNATIONAL INC (CCEL) | United States | $0.033B | -11.02 |
| MANGOCEUTICALS, INC. (MGRX) | United States | $0.010B | -0.43 |
| DAVITA INC. (DVA) | United States | $11.147B | 16.80 |